The University of Cambridge invites applications for a Research Associate to establish new experimental models to understand how nucleic acid therapeutics activate innate immune signalling. The post sits within a new collaboration between the MRC Toxicology Unit and AstraZeneca R&D, and seeks to identify molecular features and pathways that govern inflammatory or therapeutic responses.
The successful candidate will work at the interface of RNA biology, immunology and toxicology, developing
#J-18808-Ljbffr
Safer-by-Design Immune Pathway Scientist in Cambridge employer: University of Cambridge
The University of Cambridge offers a dynamic and collaborative work environment, particularly within the Department of Oncology, where you will play a pivotal role in advancing cancer research. With a strong emphasis on employee growth, you will have access to professional development opportunities and the chance to work alongside leading experts in the field. The university's commitment to innovation and excellence ensures that your contributions will have a meaningful impact on clinical care and research outcomes.
